Copyright
©The Author(s) 2019.
World J Orthop. Jan 18, 2019; 10(1): 23-32
Published online Jan 18, 2019. doi: 10.5312/wjo.v10.i1.23
Published online Jan 18, 2019. doi: 10.5312/wjo.v10.i1.23
Table 3 Floor and ceiling effects of the musculoskeletal tumour society score questionnaire
| n | Percent floor | Percent ceiling | |
| All patients | |||
| Upper extremity version | 78 | 0% | 38.5% |
| Lower extremity version | 162 | 0% | 23.5% |
| Bone sarcoma patients | |||
| Upper extremity version | 18 | 0% | 27.8% |
| Lower extremity version | 45 | 0% | 8.9% |
| Soft tissue sarcomas patients | |||
| Upper extremity version | 50 | 0% | 44% |
| Lower extremity version | 99 | 0% | 32.3% |
| Aggressive benign tumor patients | |||
| Upper extremity version | 10 | 0% | 30% |
| Lower extremity version | 18 | 0% | 11.1% |
- Citation: Saebye CKP, Keller J, Baad-Hansen T. Validation of the Danish version of the musculoskeletal tumour society score questionnaire. World J Orthop 2019; 10(1): 23-32
- URL: https://www.wjgnet.com/2218-5836/full/v10/i1/23.htm
- DOI: https://dx.doi.org/10.5312/wjo.v10.i1.23